156 related articles for article (PubMed ID: 29563185)
21. DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy.
Liu W; Deng L; Song Y; Redell M
PLoS One; 2014; 9(5):e98270. PubMed ID: 24858818
[TBL] [Abstract][Full Text] [Related]
22. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
[TBL] [Abstract][Full Text] [Related]
23. Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged Leukemia.
Barve A; Vega A; Shah PP; Ghare S; Casson L; Wunderlich M; Siskind LJ; Beverly LJ
Cells; 2019 Oct; 8(11):. PubMed ID: 31717699
[TBL] [Abstract][Full Text] [Related]
24. Structural studies of intrinsically disordered MLL-fusion protein AF9 in complex with peptidomimetic inhibitors.
Yang Y; Ahmad E; Premkumar V; Liu A; Ashikur Rahman SM; Nikolovska-Coleska Z
Protein Sci; 2024 Jun; 33(6):e5019. PubMed ID: 38747396
[TBL] [Abstract][Full Text] [Related]
25. MLL/AF10(OM-LZ)-immortalized cells expressed cytokines and induced host cell proliferation in a mouse bone marrow transplantation model.
Fu JF; Hsu CL; Shih LY
Int J Cancer; 2010 Apr; 126(7):1621-9. PubMed ID: 19711340
[TBL] [Abstract][Full Text] [Related]
26. Characterization and inhibition of AF10-mediated interaction.
Hagen S; Mattay D; Räuber C; Müller KM; Arndt KM
J Pept Sci; 2014 Jun; 20(6):385-97. PubMed ID: 24692230
[TBL] [Abstract][Full Text] [Related]
27. AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.
Deshpande AJ; Deshpande A; Sinha AU; Chen L; Chang J; Cihan A; Fazio M; Chen CW; Zhu N; Koche R; Dzhekieva L; Ibáñez G; Dias S; Banka D; Krivtsov A; Luo M; Roeder RG; Bradner JE; Bernt KM; Armstrong SA
Cancer Cell; 2014 Dec; 26(6):896-908. PubMed ID: 25464900
[TBL] [Abstract][Full Text] [Related]
28. Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENL.
Yuan Y; Du L; Tan R; Yu Y; Jiang J; Yao A; Luo J; Tang R; Xiao Y; Sun H
J Med Chem; 2022 Jun; 65(11):7770-7785. PubMed ID: 35612819
[TBL] [Abstract][Full Text] [Related]
29. The leucine zipper motif of the Drosophila AF10 homologue can inhibit PRE-mediated repression: implications for leukemogenic activity of human MLL-AF10 fusions.
Perrin L; Bloyer S; Ferraz C; Agrawal N; Sinha P; Dura JM
Mol Cell Biol; 2003 Jan; 23(1):119-30. PubMed ID: 12482966
[TBL] [Abstract][Full Text] [Related]
30. Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes.
Chang MJ; Wu H; Achille NJ; Reisenauer MR; Chou CW; Zeleznik-Le NJ; Hemenway CS; Zhang W
Cancer Res; 2010 Dec; 70(24):10234-42. PubMed ID: 21159644
[TBL] [Abstract][Full Text] [Related]
31. Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias.
Yi Y; Ge S
J Hematol Oncol; 2022 Mar; 15(1):35. PubMed ID: 35331314
[TBL] [Abstract][Full Text] [Related]
32. Targeting DOT1L action and interactions in leukemia: the role of DOT1L in transformation and development.
Barry ER; Corry GN; Rasmussen TP
Expert Opin Ther Targets; 2010 Apr; 14(4):405-18. PubMed ID: 20230194
[TBL] [Abstract][Full Text] [Related]
33. MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins.
Komata Y; Kanai A; Maeda T; Inaba T; Yokoyama A
Nat Commun; 2023 Apr; 14(1):1979. PubMed ID: 37031220
[TBL] [Abstract][Full Text] [Related]
34. A critical role for CRM1 in regulating HOXA gene transcription in CALM-AF10 leukemias.
Conway AE; Haldeman JM; Wechsler DS; Lavau CP
Leukemia; 2015 Feb; 29(2):423-32. PubMed ID: 25027513
[TBL] [Abstract][Full Text] [Related]
35. The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex.
Debernardi S; Bassini A; Jones LK; Chaplin T; Linder B; de Bruijn DR; Meese E; Young BD
Blood; 2002 Jan; 99(1):275-81. PubMed ID: 11756182
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional activation by MLL fusion proteins in leukemogenesis.
Yokoyama A
Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805
[TBL] [Abstract][Full Text] [Related]
37. Development of a multi-step leukemogenesis model of MLL-rearranged leukemia using humanized mice.
Moriya K; Suzuki M; Watanabe Y; Takahashi T; Aoki Y; Uchiyama T; Kumaki S; Sasahara Y; Minegishi M; Kure S; Tsuchiya S; Sugamura K; Ishii N
PLoS One; 2012; 7(6):e37892. PubMed ID: 22745659
[TBL] [Abstract][Full Text] [Related]
38. MLL is essential for NUP98-HOXA9-induced leukemia.
Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
[TBL] [Abstract][Full Text] [Related]
39. The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.
Klein BJ; Deshpande A; Cox KL; Xuan F; Zandian M; Barbosa K; Khanal S; Tong Q; Zhang Y; Zhang P; Sinha A; Bohlander SK; Shi X; Wen H; Poirier MG; Deshpande AJ; Kutateladze TG
Nat Commun; 2021 Jul; 12(1):4130. PubMed ID: 34226546
[TBL] [Abstract][Full Text] [Related]
40. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation.
Ono R; Kumagai H; Nakajima H; Hishiya A; Taki T; Horikawa K; Takatsu K; Satoh T; Hayashi Y; Kitamura T; Nosaka T
Leukemia; 2009 Dec; 23(12):2197-209. PubMed ID: 19710696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]